DIVZ - ETF AI Analysis
Top Page
TrueShares Low Volatility Equity Income ETF (DIVZ)
DIVZ, the TrueShares Low Volatility Equity Income ETF, earns a solid overall rating thanks to strong, income-focused holdings like MPLX, Microsoft, Johnson & Johnson, and Chevron, which combine robust financial performance with attractive dividends and long-term growth drivers. Some positions such as Altria, Philip Morris, NextEra Energy, and AbbVie introduce risks through high leverage, technical weakness, or potentially stretched valuations, and the fund’s tilt toward a handful of large dividend payers means investors should be aware of concentration risk in a relatively small group of mature, income-oriented companies.
DIVZ vs. SPDR S&P 500 ETF (SPY)
- AUM
- 314.60M
- Region
- North America
- Expense Ratio
- 0.65%
- Beta
- 0.36
- Issuer
- Polen
- Inception Date
- Jan 27, 2021
- Dividend Yield
- 2.55%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DIVZ Summary
DIVZ is the TrueShares Low Volatility Equity Income ETF, built to invest in a wide range of U.S. companies while focusing on stocks that tend to move less than the overall market. It doesn’t track a specific index, but follows a theme of stability and dividend income across sectors like energy, health care, utilities, and technology. Well-known holdings include Microsoft, Chevron, and Johnson & Johnson. Someone might invest in DIVZ to seek steady income and smoother ups and downs compared with more aggressive stock funds. A key risk is that it still invests in stocks, so its value can rise and fall with the market.
How much will it cost me?
DIVZ has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 invested. This cost is higher than the average ETF because DIVZ is actively managed, with professionals selecting low-volatility, income-focused stocks rather than simply tracking an index.
What would affect this ETF?
Future performance of DIVZ will likely benefit from stable or falling interest rates and steady economic growth in the U.S., which can support dividend-paying sectors like health care, utilities, energy, and large holdings such as UnitedHealth, Chevron, and Microsoft. On the downside, rising interest rates, stricter regulations on tobacco and energy companies, or a broad market downturn that hurts income-focused and defensive sectors could weigh on the fund’s returns despite its low-volatility approach.
DIVZ Top 10 Holdings
DIVZ leans heavily on steady, dividend-rich U.S. names, with tobacco giants Philip Morris and Altria quietly powering returns as their stocks keep rising. Health care anchors Johnson & Johnson is another bright spot, adding a calm, defensive lift, while UnitedHealth has been more mixed, losing steam in recent months. On the energy side, Chevron has been a solid engine for the fund, while pipeline player MPLX has been steady rather than exciting. NextEra Energy and UPS, both lagging lately, are more like ballast than boosters, slightly dragging on overall performance.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PM | Philip Morris | 6.37% | $20.03M | $315.85B | 35.26% | 61Neutral |
 UNH | UnitedHealth | 5.74% | $18.05M | $365.41B | 10.67% | 72Outperform |
 MPLX | MPLX | 5.75% | $18.09M | $59.75B | 16.07% | 81Outperform |
 CVX | Chevron | 5.19% | $16.32M | $452.85B | 48.71% | 71Outperform |
 JNJ | Johnson & Johnson | 4.83% | $15.20M | $652.48B | 45.00% | 78Outperform |
 MO | Altria Group | 4.40% | $13.83M | $121.87B | 15.34% | 64Neutral |
 NEE | NextEra Energy | 4.27% | $13.44M | $169.92B | -3.05% | 71Outperform |
 MSFT | Microsoft | 4.02% | $12.63M | $3.94T | -2.04% | 79Outperform |
 ABBV | AbbVie | 3.89% | $12.23M | $505.38B | 25.69% | 66Neutral |
 XOM | Exxon Mobil | 3.25% | $10.22M | $748.45B | 58.24% | 74Outperform |
DIVZ Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVZ, the sentiment is Positive. The current price of 38.13 is above the 20-day moving average (MA) of 37.41, above the 50-day MA of 37.66, and above the 200-day MA of 37.49, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 63.90 is Neutral, neither overbought nor oversold. The STOCH value of 93.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVZ.
DIVZ Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DIVZ | $38.14 | $41.00(7.51% Upside) | $314.60M | 0.65% | 69Neutral |
 SEUS | $26.00 | $30.79(18.43% Upside) | $946.37M | 0.30% | 73Outperform |
 BGDV | $31.20 | $36.87(18.19% Upside) | $891.56M | 0.45% | 74Outperform |
 AAUB | $51.12 | $61.01(19.35% Upside) | $847.44M | 0.10% | 66Neutral |
 AVTM | $54.87 | $64.60(17.73% Upside) | $780.04M | 0.22% | 60Neutral |
 SMRI | $46.79 | $56.68(21.12% Upside) | $699.37M | 0.71% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DIVZ | TrueShares Low Volatility Equity Income ETF | 38.13 | 3.86 | 11.28% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 26.00 | 0.74 | 2.91% | |
| BGDV | Bahl & Gaynor Dividend ETF | 31.20 | 4.79 | 18.14% | |
| AAUB | Alpha Architect US Equity 4 ETF | 51.12 | 1.63 | 3.30% | |
| AVTM | Avantis Total Equity Markets ETF | 54.87 | 5.23 | 10.53% | |
| SMRI | Bushido Capital US Equity ETF | 46.79 | 12.67 | 37.14% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.